Home › Funds › Squadron Capital Management LLC › RLAY

Squadron Capital Management LLC position in RLAY

RELAY THERAPEUTICS INC · Health Care

Squadron Capital Management LLC reported holding 785,000 shares of RLAY (RELAY THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$14.2M, representing 5.62% of its reported portfolio and ranking #3 among its reported holdings. Squadron Capital Management LLC has disclosed RLAY holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)785.00K sh
Reported value held$14.17M
Portfolio Weight5.62%
First reportedQ1 2026
Last changeReduce
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Squadron Capital Management LLC's RLAY position evolved

Squadron Capital Management LLC first disclosed a stake in RLAY in Q1 2026 at 150,000 shares (US$1.5M). The position peaked in Q2 2026 at 970,000 shares, worth US$18.1M. Across 3 filings, Squadron Capital Management LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 785,000 shares valued at US$14.2M — a reduction of -185,000 shares quarter over quarter.. Notable position changes include a 547% increase in Q2 2026 (shares fell 4% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 150.00K $1.49M New
Q2 2026 970.00K $18.15M Add
Q3 2026 785.00K $14.17M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RLAY and 13F data

RLAY (RELAY THERAPEUTICS INC) is a Health Care company. 55 other funds we track also report a position in RLAY — the largest reported positions include SB INVESTMENT ADVISERS (UK) LTD (US$522.1M), Casdin Capital (US$289.4M), PERCEPTIVE ADVISORS LLC (US$229.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RLAY

All RLAY fund holders →

FAQ

How long has Squadron Capital Management LLC held RLAY?

Squadron Capital Management LLC has disclosed RLAY holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Squadron Capital Management LLC's current position in RLAY?

As of Q3 2026, Squadron Capital Management LLC holds 785.00K shares of RLAY (RELAY THERAPEUTICS INC), valued at $14.17M, representing 5.62% of its reported portfolio and ranking #3.

Has Squadron Capital Management LLC been buying or selling RLAY?

In the latest 13F filing (Q3 2026), Squadron Capital Management LLC reduced its position in RLAY. The position peaked in Q2 2026 at 970.00K shares.

Which other funds hold RLAY?

Other major institutional holders of RLAY include SB INVESTMENT ADVISERS (UK) LTD, Casdin Capital, PERCEPTIVE ADVISORS LLC, among 55 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.